HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
HARP
Delisted
HARP was delisted on the 8th of March, 2024.
79 hedge funds and large institutions have $128M invested in Harpoon Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
35% less capital invested
Capital invested by funds: $196M → $128M (-$68.1M)
Holders
79
Holding in Top 10
3
Calls
$193K
Puts
$185K
Top Buyers
| 1 | +$2.58M | |
| 2 | +$2.47M | |
| 3 | +$2.24M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.29M |
| 5 |
Renaissance Technologies
New York
|
+$793K |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$3.59M | |
| 3 | -$1.78M | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$1.16M |
| 5 |
Two Sigma Investments
New York
|
-$887K |